Role of endogenous atrial natriuretic peptide in DOCA-salt hypertensive rats. Effects of a novel nonpeptide antagonist for atrial natriuretic peptide receptor. | Zendy

Yoko Hirata | Zendy; Hideki Matsuoka | Zendy; Emiko Suzuki | Zendy; Hiroshi Hayakawa | Zendy; T Sugimoto | Zendy; Y Matsuda | Zendy; Yoshikazu Morishita | Zendy; Kenji Kangawa | Zendy; Naoto Minamino | Zendy; H. Matsuo | Zendy

Open Access

Role of endogenous atrial natriuretic peptide in DOCA-salt hypertensive rats. Effects of a novel nonpeptide antagonist for atrial natriuretic peptide receptor.

Author(s) -

Yoko Hirata,

Hideki Matsuoka,

Emiko Suzuki,

Hiroshi Hayakawa,

T Sugimoto,

Y Matsuda,

Yoshikazu Morishita,

Kenji Kangawa,

Naoto Minamino,

H. Matsuo

Publication year - 1993

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/01.cir.87.2.554

Subject(s) - medicine , atrial natriuretic peptide , antagonist , npr2 , npr1 , endogeny , endocrinology , natriuretic peptide , peptide , peptide hormone , cardiology , receptor , heart failure , biochemistry , chemistry

To explore roles of endogenous atrial natriuretic peptide (ANP) in blood pressure and volume regulation, we examined the effects of a newly developed ANP antagonist, HS-142-1 (HS) in deoxycorticosterone acetate (DOCA)-salt hypertensive rats.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research